InfuSystem Holdings (INFU) EBITDA Margin (QoQ) (2010 - 2026)
InfuSystem Holdings (INFU) EBITDA Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.43 Bn | 196.83 Bn | 7.27 Bn |
| 2 | Stryker | 126.52 Bn | 123.04 Bn | 4.50 Bn |
| 3 | Medtronic | 119.07 Bn | 109.85 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.59 Bn | 47.34 Bn | 1.35 Bn |
| 6 | Dexcom | 34.95 Bn | 33.00 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.72 Bn | 31.61 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.20 Bn | 22.88 Bn | 4.55 Bn |
| 9 | Steris | 23.16 Bn | 22.68 Bn | 684.20 Mn |
| 10 | InfuSystem Holdings | 242.86 Mn | 241.90 Mn | 21.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 652.00 |
| Mar 31, 2026 | -553.00 |
| Dec 31, 2025 | -19.00 |
| Sep 30, 2025 | -5.00 |
| Jun 30, 2025 | 871.00 |
| Mar 31, 2025 | -595.00 |
| Dec 31, 2024 | -152.00 |
| Sep 30, 2024 | 374.00 |
| Jun 30, 2024 | 815.00 |
| Mar 31, 2024 | -658.00 |
| Dec 31, 2023 | -138.00 |
| Sep 30, 2023 | 139.00 |
| Jun 30, 2023 | 428.00 |
| Mar 31, 2023 | -392.00 |
| Dec 31, 2022 | 11.00 |
| Sep 30, 2022 | 269.00 |
| Jun 30, 2022 | 273.00 |
| Mar 31, 2022 | -800.00 |
| Dec 31, 2021 | 736.00 |
| Sep 30, 2021 | -412.00 |